Skip to main content
Fig. 6 | The Journal of Headache and Pain

Fig. 6

From: The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials

Fig. 6

The pooled RR of ≥ 50% reduction in adverse events. The blue square indicates the estimated RR for each RCT. The size of blue square indicates the estimated weight of each RCT, and the extending lines indicate the estimated 95% CI of RR for each RCT. The black diamond indicates the estimated RR (95% CI) for all patients together. CI, confidence interval; RCT, randomized controlled trial; RR: risk ratio

Back to article page